Protest Trial: TXA vs Saline

Phase 3 Enrolling by invitation 94 enrolled Corewell Health West

RandomizedParallel-groupTriple-blindPrevention

Summary

To determine if endobronchial (topical) tranexamic acid used prophylactically prior to performing transbronchial biopsies in lung transplant recipients reduces bleeding risk.

Timeline

Start: 2024-04-16
Primary completion: 2026-06-30
Completion: 2027-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tranexamic Acid	Small molecule	—	Topical

Indications

No indication recorded.